Novolog (Pharm UP 1966) Ltd. engages in the provision of healthcare services. The firm is a logistical partner for domestic and multinational pharmaceutical and medical device companies operating in Israel. The company mainly serves pharmacies, hospitals, and patients at home. The firm operates through its subsidiaries, which include: Care for Life-Professional Nurses Service, which provides a range of in-home services for patients by trained nurses and trained assistants, as well as Trialog-Clinical Trial Logistics, which specializes in logistics for clinical trials and works with pharmaceutical and Clinical Research Organization (CRO) companies that perform clinical trials in Israel.
Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for NVLGF. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: NVLGF is a Buy candidate.
NVLGF stock price ended at $0 on 星期日, after dropping NaN%
On the latest trading day Jan 18, 2026, the stock price of NVLGF fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for NVLGF decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.